Dianthus Therapeutics DNTH Personnel And Related Costs — General And Administrative Expense
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's personnel and related costs — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's personnel and related costs — general and administrative expense?
- Dianthus Therapeutics (DNTH) reported personnel and related costs — general and administrative expense of $4.06M in Q1 2026.
- How has Dianthus Therapeutics's personnel and related costs — general and administrative expense changed year-over-year?
- Dianthus Therapeutics's personnel and related costs — general and administrative expense increased by 58.6% year-over-year, from $2.56M to $4.06M.
- What does personnel and related costs — general and administrative expense mean?
- This metric captures the personnel-related expenses, including salaries and benefits, for employees working in non-research functions such as executive management, finance, legal, and human resources. It serves as a measure of the company's operational overhead and the cost of supporting the corporate infrastructure required to sustain business activities. Tracking this metric allows stakeholders to evaluate the efficiency of the company's administrative support structure relative to its growth stage.